spiperone has been researched along with fluorodeoxyglucose f18 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wagner, HN | 1 |
| Dewey, SL; Fowler, JS; Hitzemann, R; Logan, J; Schlyer, DJ; Volkow, ND; Wang, GJ; Wolf, AP | 1 |
| Arnold, S; Engelbrecht, V; Hefter, H; Kuwert, T; Schlaug, G; Seitz, RJ; Stöcklin, G | 1 |
| Conley, RR; Tamminga, CA | 1 |
| Araujo, DM; Cherry, SR; Kornblum, HI; Tatsukawa, KJ; Toyokuni, T | 1 |
| Alenius, S; Bettinardi, V; Fazio, F; Gilardi, MC; Pagani, E; Teras, M; Thielemans, K | 1 |
| Fang, S; Shen, G; Tian, M; Yang, X; Zhang, H; Zhao, C; Zheng, X | 1 |
1 review(s) available for spiperone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
The application of neuroimaging techniques to drug development.
Topics: Antipsychotic Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Diagnostic Imaging; Drug Industry; Drugs, Investigational; Fluorodeoxyglucose F18; Haloperidol; Humans; Ketamine; Magnetic Resonance Imaging; Mental Disorders; Neuropharmacology; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
1 trial(s) available for spiperone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI.
Topics: Adult; Brain Chemistry; Chelating Agents; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Neostriatum; Nervous System; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1996 |
5 other study(ies) available for spiperone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Rett syndrome: positron emission tomography (PET) studies.
Topics: Adult; Age Factors; Aged; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intellectual Disability; Male; Middle Aged; Movement Disorders; Receptors, Dopamine; Spiperone; Syndrome; Time Factors; Tomography, Emission-Computed | 1986 |
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
Topics: Adult; Brain; Cocaine; Deoxyglucose; Dopamine Agents; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Receptors, Dopamine D2; Reference Values; Spiperone; Substance-Related Disorders; Tomography, Emission-Computed | 1993 |
Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Topics: Animals; Autoradiography; Benzazepines; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Energy Metabolism; Female; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Huntington Disease; In Situ Hybridization; Nerve Degeneration; Neurotoxins; Quinolinic Acid; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Substantia Nigra; Tomography, Emission-Computed; Tritium | 2000 |
Implementation and evaluation of a 3D one-step late reconstruction algorithm for 3D positron emission tomography brain studies using median root prior.
Topics: Algorithms; Brain; Caudate Nucleus; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Phantoms, Imaging; Putamen; Radiopharmaceuticals; Spiperone; Tomography, Emission-Computed | 2002 |
11C-NMSP/ 18F-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury.
Topics: Animals; Brain Injuries; Carbon Radioisotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Gene Expression Regulation; Immunohistochemistry; Neurons; Positron-Emission Tomography; Rats; Receptors, Dopamine D2; Spiperone; Stem Cell Transplantation | 2008 |